Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3707204016 | Product containing technetium (99m-Tc) fanolesomab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
3707205015 | Technetium (99m-Tc) fanolesomab-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing technetium (99m-Tc) fanolesomab in parenteral dose form (medicinal product form) | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
Product containing technetium (99m-Tc) fanolesomab in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
Product containing technetium (99m-Tc) fanolesomab in parenteral dose form (medicinal product form) | Has active ingredient | Technetium (99m-Tc) fanolesomab (substance) | true | Inferred relationship | Some | 1 | |
Product containing technetium (99m-Tc) fanolesomab in parenteral dose form (medicinal product form) | Is a | Product containing technetium-99m (medicinal product) | false | Inferred relationship | Some | ||
Product containing technetium (99m-Tc) fanolesomab in parenteral dose form (medicinal product form) | Is a | Technetium-99m-containing product in parenteral dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets